REGIONAL BLOOD-FLOW EFFECTS OF DOPEXAMINE VERSUS ENALAPRILAT DURING PROPOFOL ANESTHESIA IN RABBITS WITH EXPERIMENTAL CHRONIC HEART-FAILURE

Objective: Chronic congestive heart failure (CHF) was induced in rabbi ts with doxorubicin in order to evaluate: (1) haemodynamic and regiona l blood flow responses to propofol anaesthesia; (2) modification of th ese cardiovascular responses with background intravenous infusions of enalaprilat or dopexamine. Methods: Rabbits received either doxorubici n, 2 mg.kg(-1) weekly intravenously for seven weeks (CHF, n = 6), or s aline (controls, n = 6). Doppler flow probes were implanted on the asc ending aorta, left renal artery, and lower abdominal aorta. In three s eparate studies propofol was infused for 40 min periods at 0.6 and the n 1.2 mg.kg(-1).min(-1) after background infusions of either saline, e nalaprilat (0.2 mg.kg(-1) + 0.003 mg.kg(-1).min(-1)), or dopexamine (0 .008 mg.kg(-1).min(-1)). Results: In normal rabbits propofol (1.2 mg.k g(-1).min(-1)) reduced mean arterial pressure from awake control by 33 (SEM 3)%, cardiac output by 24(4)%, and hindlimb blood flow (HBF) by 1 0(2)%, but did not change renal blood flow. In rabbits with CHF althou gh resting mean blood pressure was lower, propofol did not alter blood pressure or hindlimb blood flow, but renal blood flow was reduced by 37(6)%. Conclusions: Both enalaprilat and dopexamine increased renal b lood flow in the control and CHF groups. Enalaprilat caused marked hyp otension during anaesthesia in the CHF group. Dopexamine increased mea n arterial pressure, heart rate, and hindlimb blood flow during anaest hesia in controls, but not in CHF.